Literature DB >> 27183576

Vitamin A Controls the Presence of RORγ+ Innate Lymphoid Cells and Lymphoid Tissue in the Small Intestine.

Gera Goverse1, Carlos Labao-Almeida2, Manuela Ferreira2, Rosalie Molenaar1, Sigrid Wahlen1, Tanja Konijn1, Jasper Koning1, Henrique Veiga-Fernandes2, Reina E Mebius3.   

Abstract

Changes in diet and microbiota have determining effects on the function of the mucosal immune system. For example, the active metabolite of vitamin A, retinoic acid (RA), has been described to maintain homeostasis in the intestine by its influence on both lymphocytes and myeloid cells. Additionally, innate lymphoid cells (ILCs), important producers of cytokines necessary for intestinal homeostasis, are also influenced by vitamin A in the small intestines. In this study, we show a reduction of both NCR(-) and NCR(+) ILC3 subsets in the small intestine of mice raised on a vitamin A-deficient diet. Additionally, the percentages of IL-22-producing ILCs were reduced in the absence of dietary vitamin A. Conversely, mice receiving additional RA had a specific increase in the NCR(-) ILC3 subset, which contains the lymphoid tissue inducer cells. The dependence of lymphoid tissue inducer cells on vitamin A was furthermore illustrated by impaired development of enteric lymphoid tissues in vitamin A-deficient mice. These effects were a direct consequence of ILC-intrinsic RA signaling, because retinoic acid-related orphan receptor γt-Cre × RARα-DN mice had reduced numbers of NCR(-) and NCR(+) ILC3 subsets within the small intestine. However, lymphoid tissue inducer cells were not affected in these mice nor was the formation of enteric lymphoid tissue, demonstrating that the onset of RA signaling might take place before retinoic acid-related orphan receptor γt is expressed on lymphoid tissue inducer cells. Taken together, our data show an important role for vitamin A in controlling innate lymphoid cells and, consequently, postnatal formed lymphoid tissues within the small intestines.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183576     DOI: 10.4049/jimmunol.1501106

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection.

Authors:  Panagiota Mamareli; Friederike Kruse; Chia-Wen Lu; Melanie Guderian; Stefan Floess; Katharina Rox; David S J Allan; James R Carlyle; Mark Brönstrup; Rolf Müller; Luciana Berod; Tim Sparwasser; Matthias Lochner
Journal:  Mucosal Immunol       Date:  2020-04-30       Impact factor: 7.313

Review 2.  Neuroimmune regulation during intestinal development and homeostasis.

Authors:  Henrique Veiga-Fernandes; Vassilis Pachnis
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

3.  Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis.

Authors:  Mayara Grizotte-Lake; Guo Zhong; Kellyanne Duncan; Jay Kirkwood; Namrata Iyer; Irina Smolenski; Nina Isoherranen; Shipra Vaishnava
Journal:  Immunity       Date:  2018-12-18       Impact factor: 31.745

Review 4.  Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut.

Authors:  Wenqing Zhou; Gregory F Sonnenberg
Journal:  Trends Immunol       Date:  2020-07-06       Impact factor: 16.687

5.  IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.

Authors:  Catherine H Poholek; Sarah J Dulson; Allan J Zajac; Laurie E Harrington
Journal:  Immunohorizons       Date:  2019-06-04

6.  STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.

Authors:  Matthew T Stier; Kasia Goleniewska; Jacqueline Y Cephus; Dawn C Newcomb; Taylor P Sherrill; Kelli L Boyd; Melissa H Bloodworth; Martin L Moore; Kong Chen; Jay K Kolls; R Stokes Peebles
Journal:  J Immunol       Date:  2017-06-02       Impact factor: 5.422

7.  The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine.

Authors:  Adam K Savage; Hong-Erh Liang; Richard M Locksley
Journal:  J Immunol       Date:  2017-07-26       Impact factor: 5.422

Review 8.  What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk.

Authors:  Clément Caffaratti; Caroline Plazy; Geoffroy Mery; Abdoul-Razak Tidjani; Federica Fiorini; Sarah Thiroux; Bertrand Toussaint; Dalil Hannani; Audrey Le Gouellec
Journal:  Metabolites       Date:  2021-06-21

9.  Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.

Authors:  Ivana Stojanović; Tamara Saksida; Đorđe Miljković; Nada Pejnović
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

Review 10.  Development and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the Colon.

Authors:  Manuela Buettner; Matthias Lochner
Journal:  Front Immunol       Date:  2016-09-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.